The company
Wave Life Sciences, Inc.
WVE · Nasdaq
WVE stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 30 weeks. It is 42.6% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 30
- Industry in uptrend
- 18% -14 in 4 wk
- Insider buys, 12 months
- $137.2M
- Insider sales, 12 months
- $17.2M
- Officials’ trades on record
- 0
- Institutions holding
- 228 (+10)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Adrian RawcliffeDirector | sold | 12,700at $5.29 | 12 Aug 2026filed 13 Aug 2026 |
| Aik Na TanDirector | sold | 432at $6.01 | 11 Aug 2026filed 13 Aug 2026 |
| Ken TakanashiDirector | sold | 3,864at $6.01 | 11 Aug 2026filed 13 Aug 2026 |
| Heidi L. WagnerDirector | sold | 7,000at $6.01 | 11 Aug 2026filed 13 Aug 2026 |
| Ra Capital Management, L.p.Director, 10% owner | bought | 971,091at $6.50 | 30 Mar 2026filed 30 Mar 2026 |
| Ra Capital Management, L.p.Director, 10% owner | bought | 2,495,623at $6.43 | 27 Mar 2026filed 30 Mar 2026 |
| Ra Capital Management, L.p.Director, 10% owner | bought | 4,954,558at $6.06 | 26 Mar 2026filed 30 Mar 2026 |
| Ra Capital Management, L.p.Director, 10% owner | bought | 351,224at $6.38 | 26 Mar 2026filed 30 Mar 2026 |
| Chris FrancisOfficer | sold | 17,900at $15.09 | 26 Feb 2026filed 27 Feb 2026 |
| Chris FrancisOfficer | sold | 15,294at $15.00 | 26 Feb 2026filed 27 Feb 2026 |
| Chandra VargeeseOfficer | sold | 3,228at $13.45 | 9 Feb 2026filed 11 Feb 2026 |
| Chris FrancisOfficer | sold | 1,883at $13.45 | 9 Feb 2026filed 11 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026 | 26,975,505$156.7M | 00.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 19,202,461$111.6M | +5,085,049+36.0% |
| GSK plcunchanged · filed 13 Aug 2026 | 18,245,691$106.0M | 00.0% |
| MAVERICK CAPITAL LTDadded · filed 14 Aug 2026 | 10,278,115$59.7M | +116,716+1.1% |
| Driehaus Capital Management LLCadded · filed 14 Aug 2026 | 5,443,143$31.6M | +12,122+0.2% |
| PRIMECAP MANAGEMENT COadded · filed 14 Aug 2026 | 5,354,622$31.1M | +521,670+10.8% |
| 683 Capital Management, LLCadded · filed 14 Aug 2026 | 4,950,000$28.8M | +50,000+1.0% |
| FMR LLCreduced · filed 13 Aug 2026 | 4,922,477$28.6M | -270,284−5.2% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 4,839,317$28.1M | +1,165,284+31.7% |
| READYSTATE ASSET MANAGEMENT LPnew · filed 14 Aug 2026 | 4,727,139$27.5M | +4,727,139 |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.